An observational study on etiology of sepsis patients admitted to ICU
Keywords:
sepsis, septic shock, Acinetobacter baumannii, Intensive Care Units, Pseudomonas aeruginosa, KlebsiellaAbstract
Background: Despite the fact that sepsis is one of the main causes of death in hospitalized patients, there is a scarcity of data on early predictors of mortality and morbidity.
Aims and Objectives: We performed this study to identify the etiology of patients with sepsis in GMC, Srinagar.
Methods: A prospective longitudinal study was done in our intensive care unit from March 2019 to September 2019. Our study included all 100 adult patients hospitalized to the intensive care unit with signs of sepsis or septic shock.
Results: In 60 % of the cases, microbiological documentation was available. Gram negative organisms caused the vast majority of illnesses. The respiratory tract was the most common source of infection. The microbial organisms commonly isolated were A. Baumannii in 22 percent of cases, P. Aeruginosa in 17 percent of cases and equal number of cases of Klebsiella and E. coli in 16 percent.
Conclusions: Sepsis is a serious health issue that has a significant mortality rate in the Intensive care unit in the Srinagar, J&K, and the mortality is female dominated.
Downloads
References
1. Singer M, Deutschman CS, Warren Seymour C, Shankar Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA [Internet]. 2016 [citado 23 Sep 2021];315(8):801–10. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968574/pdf/nihms794087.pdf
2. Jarczak D, Kluge S, Nierhaus A. Sepsis—Pathophysiology and Therapeutic Concepts. Front. Med [Internet]. 2021 [citado 23 Sep 2021];8:[aprox. 22 p.]. Disponible en: https://www.frontiersin.org/articles/10.3389/fmed.2021.628302/pdf
3. Sakr Y, Jaschinski U, Wittebole X, Szakmany T, Lipman J, Ñamendys Silva SA, et al. Sepsis in Intensive Care Unit Patients: Worldwide Data From the Intensive Care over Nations Audit. Open Forum Infect Dis [Interne]. 2018 [citado 23 Sep 2021];5(12):[aprox. 9 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289022/pdf/ofy313.pdf
4. Abera Mulatu H, Bayisa T, Worku Y, Lazarus JJ, Woldeyes E, Bacha D, et al. Prevalence and outcome of sepsis and septic shock in intensive care units in Addis Ababa, Ethiopia: A prospective observational study. Afr J Emerg Med [Internet]. 2021 [citado 23 Sep 2021];11(1):188–95. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910175/pdf/main.pdf
5. Fleischmann Struzek C, Mellhammar L, Rose N, Cassini A, Rudd KE, Schlattmann P, Allegranzi B, et al. Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Medicine [Internet]. 2020 [citado 23 Sep 2021];46:1552–62. Disponible en: https://link.springer.com/article/10.1007/s00134-020-06151-x
6. Shankar Har M, Harrison DA, Rubenfeld GD, Rowan K. Epidemiology of sepsis and septic shock in critical care units: comparison between sepsis-2 and sepsis-3 populations using a national critical care database. British Journal of Anaesthesia [Internet]. 2017 [citado 23 Sep 2021];119(4):626-36. Disponible en: https://www.sciencedirect.com/science/article/pii/S0007091217538003
7. Lee J, Levy MM. Treatment of Patients with Severe Sepsis and Septic Shock: Current Evidence-Based Practices. Rev RIMJ [Internet]. 2019 [citado 23 Sep 2021];102(10):18-21. Disponible en: http://rimed.org/rimedicaljournal/2019/12/2019-12-18-ccm-lee.pdf
8. Ramachandran G. Gram-positive and gram-negative bacterial toxins in sepsis. Virulence [Internet]. 2014 [citado 23 Sep 2021];5(1):213–8. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916377/pdf/viru-5-213.pdf
9. Kline KA, Lewis AL. Gram-Positive Uropathogens, Polymicrobial Urinary Tract Infection, and the Emerging Microbiota of the Urinary Tract. Microbiol Spectr [Internet]. 2016 [citado 23 Sep 2021];4(2):10-21. Disponible en: https://journals.asm.org/doi/epub/10.1128/microbiolspec.UTI-0012-2012
10. UpToDate [Internet]. USA: UpToDate, Inc; 2021 [citado 23 Sep 2021]. Schmidt GA, Mandel J. Evaluation and management of suspected sepsis and septic shock in adults. Disponible en: https://www.uptodate.com/contents/evaluation-and-management-of-suspected-sepsis-and-septic-shock-in-adults/print
11. Chelkeba L, Melaku T, Mega TA. Gram-Negative Bacteria Isolates and Their Antibiotic-Resistance Patterns in Patients with Wound Infection in Ethiopia: A Systematic Review and Meta-Analysis. Infection and Drug Resistance [Internet]. 2021 [citado 23 Sep 2021];14:277–30. Disponible en: https://www.dovepress.com/getfile.php?fileID=66082
12. Zhang H, Johnson A, Zhang G, Yang y, Zhang J, Li D, et al. Susceptibilities of Gram-negative bacilli from hospital- and community-acquired intra-abdominal and urinary tract infections: a 2016-2017 update of the Chinese SMART study. Infect Drug Resist [Internet]. 2019 [citado 23 Sep 2021];12:905-14. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503304/pdf/idr-12-905.pdf
13. Puca V, Marulli RZ, Grande R, Vitale I, Niro A, Molinaro G, Prezioso S, et al. Microbial Species Isolated from Infected Wounds and Antimicrobial Resistance Analysis: Data Emerging from a Three-Years Retrospective Study. Antibiotics [Internet]. 2021 [citado 23 Sep 2021];10(10):1162-76. Disponible en: https://www.mdpi.com/2079-6382/10/10/1162
14. Evans L, Rhodes A, Levy M. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med [Interne]. 2021 [citado 23 Sep 2021];47:1181–1247. Disponible en: https://link.springer.com/content/pdf/10.1007/s00134-021-06506-y.pdf
15. Rhee C, Jones TM, Hamad Y. Prevalence, Underlying Causes, and Preventability of Sepsis-Associated Mortality in US Acute Care Hospitals. JAMA Netw Open [Interne]. 2019 [citado 23 Sep 2021];2(2):[aprox. 14 p.]. Disponible en: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2724768
16. Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. The Lancet [Internet]. 2020 [citado 23 Sep 2021];395(10219):200–11 Disponible en: https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(19)32989-7.pdf
17. Paary TTS, Kalaiselvan ST, Renuka MK, Arunkumar AS. Clinical profile and outcome of patients with severe sepsis treated in an intensive care unit in India. Ceylon Medical Journal [Internet]. 2016 [citado 23 Sep 2021];61(4):181-4. Disponible en: https://www.researchgate.net/publication/312302937_Clinical_profile_and_outcome_of_patients_with_severe_sepsis_treated_in_an_intensive_care_unit_in_India
18. Healy M. National Sepsis Outcome Report 2018 [Internet]. Ireland: Sepsis Steering Committee; 2019 [citado 23 Sep 2021]. Disponible en: https://www.hse.ie/eng/about/who/cspd/ncps/sepsis/resources/national-sepsis-report-2018.pdf
19. Shankar Hari M. Harrison DA, Rubenfeld GD, Rowan K. Epidemiology of sepsis and septic shock in critical care units: comparison between sepsis-2 and sepsis-3 populations using a national critical care database. British Journal of Anaesthesia [Internet]. 2017 [citado 23 Sep 2021];119(4):626-36. Disponible en: https://www.bjanaesthesia.org/action/showPdf?pii=S0007-0912%2817%2953800-3
20. Lin GL, McGinley JP, Drysdale SB, Pollard AJ. Epidemiology and Immune Pathogenesis of Viral Sepsis. Front Immunol [Internet]. 2018 [citado 23 Sep 2021];9:2147-68. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170629/pdf/fimmu-09-02147.pdf
21. Responsible management of sepsis, severe infection and antimicrobial stewardship [Internet]. En: The Sepsis Manual. 4th ed. Birmingham: United Kingdom Sepsis Trust; 2017 [citado 23 Sep 2021]. Disponible en: https://sepsistrust.org/wp-content/uploads/2018/06/Sepsis_Manual_2017_web_download.pdf
22. Divatia VJ, Pravin RA, Ramakrishnan N, Kapadia FN, Todi S, Sahu S, et al. Intensive care in India: The Indian intensive care case mix and practice patterns study. Indian J Crit Care Med [Internet]. 2016 [citado 23 Sep 2021];20(4):216-25. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859158/
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: authors retain their copyright and grant the journal the right of first publication of their work, which is simultaneously subject to the Creative Commons Attribution-NonCommercial 4.0 International License that allows third parties to share the work as long as the author and first publication in this journal are indicated, for non-commercial use. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional telematic archive or publishing it in a monographic volume) as long as the initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work via the Internet (e.g., in institutional telematic archives, in their web page or in Pre-print servers) before and during the submission process, which can lead to interesting exchanges and increase citations of the published work. (See The Open Access Effect).
